HutchMED (China) LIMITED Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HutchMED (China) LIMITED stock issued during period, value, stock options exercised for the quarter ending 2019-12-31 was $96.00K, a 96.03% decline year-over-year.
- HutchMED (China) LIMITED stock issued during period, value, stock options exercised for the quarter ending 2018-12-31 was $2.42M.
- HutchMED (China) LIMITED stock issued during period, value, stock options exercised for the quarter ending 2018-09-30 was $24.00K.
- HutchMED (China) LIMITED stock issued during period, value, stock options exercised for the quarter ending 2018-06-30 was $466.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $1.58M 20-F · filed 2026-03-05 | |
| 2024-12-31 | $790.00K 20-F · filed 2026-03-05 | |
| 2023-12-31 | $5.09M 20-F · filed 2026-03-05 | |
| 2022-12-31 | $174.00K 20-F · filed 2025-03-19 | |
| 2021-12-31 | $2.45M 20-F · filed 2024-02-28 | |
| 2020-12-31 | $593.00K 20-F · filed 2023-02-28 | |
| 2019-12-31 | $96.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $251.00K 20-F · filed 2022-03-03 |
| 2018-12-31 | $2.42M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $3.16M 20-F · filed 2021-03-04 |
| 2018-09-30 | $24.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | |
| 2018-06-30 | $466.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | |
| 2018-03-31 | $254.00K 6-K · filed 2019-06-06 | |
| 2017-12-31 | $380.00K 20-F · filed 2020-03-03 | |
| 2016-12-31 | $426.00K 20-F · filed 2019-03-11 | |
| 2015-12-31 | $1.37M 20-F · filed 2018-03-12 | |
| 2014-12-31 | $2.68M 20-F · filed 2017-03-13 |